M. W. Whitehouse

1.0k total citations · 1 hit paper
26 papers, 819 citations indexed

About

M. W. Whitehouse is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, M. W. Whitehouse has authored 26 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in M. W. Whitehouse's work include Inflammatory mediators and NSAID effects (4 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). M. W. Whitehouse is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). M. W. Whitehouse collaborates with scholars based in Australia, United States and United Kingdom. M. W. Whitehouse's co-authors include P. B. Ghosh, P. W. Kent, F. Zilliken, James W. Lash, Antonio Moretti, Howard Holtzer, F W Beck, ERT Tiekink, A Lorber and Carl M. Pearson and has published in prestigious journals such as Nature, Analytical Biochemistry and FEBS Letters.

In The Last Decade

M. W. Whitehouse

26 papers receiving 720 citations

Hit Papers

7-chloro-4-nitrobenzo-2-oxa-1,3-diazole: a new fluorigeni... 1968 2026 1987 2006 1968 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. W. Whitehouse Australia 14 316 172 123 82 78 26 819
David H. Leaback United Kingdom 12 567 1.8× 268 1.6× 75 0.6× 113 1.4× 47 0.6× 40 1.0k
Th. Posternak France 16 395 1.3× 302 1.8× 67 0.5× 59 0.7× 85 1.1× 54 944
Milton Tabachnick United States 19 546 1.7× 100 0.6× 173 1.4× 177 2.2× 147 1.9× 38 1.3k
E Boccù Italy 15 434 1.4× 95 0.6× 70 0.6× 54 0.7× 80 1.0× 47 728
D.G. Herries United Kingdom 14 720 2.3× 138 0.8× 62 0.5× 136 1.7× 65 0.8× 35 1.1k
Günther Weitzel Germany 18 481 1.5× 190 1.1× 59 0.5× 75 0.9× 101 1.3× 108 1.0k
D.R. Grassetti United States 14 735 2.3× 164 1.0× 105 0.9× 164 2.0× 209 2.7× 21 1.4k
J. P. TENGI United States 9 642 2.0× 246 1.4× 162 1.3× 57 0.7× 44 0.6× 12 1.1k
Kay Fink United States 19 1.1k 3.4× 164 1.0× 79 0.6× 67 0.8× 172 2.2× 27 1.7k
J. A. R. Mead United States 15 407 1.3× 151 0.9× 47 0.4× 33 0.4× 33 0.4× 51 953

Countries citing papers authored by M. W. Whitehouse

Since Specialization
Citations

This map shows the geographic impact of M. W. Whitehouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. W. Whitehouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. W. Whitehouse more than expected).

Fields of papers citing papers by M. W. Whitehouse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. W. Whitehouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. W. Whitehouse. The network helps show where M. W. Whitehouse may publish in the future.

Co-authorship network of co-authors of M. W. Whitehouse

This figure shows the co-authorship network connecting the top 25 collaborators of M. W. Whitehouse. A scholar is included among the top collaborators of M. W. Whitehouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. W. Whitehouse. M. W. Whitehouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghosh, Parasar, et al.. (2008). Cartilage derived peptacans: novel nutraceuticals with immunomodulatory, anti-inflammatory and anti-arthritic activities. Current Topics in Nutraceutical Research. 6(2). 83–98. 1 indexed citations
2.
Haritos, Victoria S., et al.. (1994). Ammonium 4-Chloro-7-sulfobenzofurazan: A Fluorescent Substrate Highly Specific for Rat Glutathione S-Transferase Subunit 3. Analytical Biochemistry. 216(2). 418–423. 8 indexed citations
3.
Tiekink, ERT, et al.. (1994). Phosphinegold(I) Complexes Containing the Purine-6-thiolate Anion, and Their Antiarthritic Activity. Australian Journal of Chemistry. 47(4). 577–586. 30 indexed citations
4.
Siddiqui, Ovais, et al.. (1992). Preparation and Properties of a Glycerolatocalcium Complex. Australian Journal of Chemistry. 45(7). 1179–1185. 7 indexed citations
5.
Fairlie, David P., M. W. Whitehouse, & R. M. Taylor. (1992). Zinc monoglycerolate — A slow-release source of therapeutic zinc: Solubilization by endogenous ligands. Inflammation Research. 36(1-2). 152–158. 18 indexed citations
6.
Haynes, David R., M. W. Whitehouse, & B. Vernon‐Roberts. (1991). The effects of some anti-arthritic drugs and cytokines on the shape and function of rodent macrophages.. PubMed. 72(1). 9–22. 7 indexed citations
7.
Forbes, Ian J., Peter D. Zalewski, N P Hurst, C. Giannakis, & M. W. Whitehouse. (1989). Zinc increases phorbol ester receptors in intact B‐cells, neutrophil polymorphs and platelets. FEBS Letters. 247(2). 445–447. 26 indexed citations
8.
Walker, WR, et al.. (1981). Dermal copper drugs: the copper bracelet and cu(II) salicylate complexes.. PubMed. 8. 359–67. 12 indexed citations
9.
Whitehouse, M. W.. (1977). Immunological Adjuvants—Report of a WHO Scientific Group: WHO Tech. Rep. Ser. 559. Immunology. 33(3). 433. 5 indexed citations
10.
Whitehouse, M. W., et al.. (1977). Pathobiodynamics: Reduced Ascorbate Excretion by Rats with Severe Inflammation. Experimental Biology and Medicine. 155(3). 361–364. 4 indexed citations
11.
Baumgartner, Werner A., F W Beck, A Lorber, Carl M. Pearson, & M. W. Whitehouse. (1974). Adjuvant Disease in Rats: Biochemical Criteria for Distinguishing Several Phases of Inflammation and Arthritis. Experimental Biology and Medicine. 145(2). 625–630. 47 indexed citations
12.
Beck, F W & M. W. Whitehouse. (1974). I. Drug Sensitivity of Rat Adjuvant Arthritis, Induced with 'Adjuvants' Containing no Mineral Oil Components. Experimental Biology and Medicine. 146(3). 665–669. 4 indexed citations
13.
Ghosh, P. B. & M. W. Whitehouse. (1968). 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole: a new fluorigenic reagent for amino acids and other amines. Biochemical Journal. 108(1). 155–156. 304 indexed citations breakdown →
14.
Fisher, D A, M. W. Whitehouse, & P. W. Kent. (1967). β-Xylosidase and β-Galactosidase Activities of Mammalian Connective Tissues and Other Sources. Nature. 213(5072). 204–205. 13 indexed citations
15.
Moretti, Antonio & M. W. Whitehouse. (1963). Changes in the mucopolysaccharide composition of bovine heart valves with age. Biochemical Journal. 87(2). 396–402. 42 indexed citations
16.
Whitehouse, M. W. & F. Zilliken. (1960). Isolation and Determination of Neuraminic (Sialic) Acids. Methods of biochemical analysis. 8. 199–220. 36 indexed citations
17.
Whitehouse, M. W. & P. W. Kent. (1958). Synthesis of methyl 2-acetamido-2-deoxy-β-D-glucofuranoside. Tetrahedron. 4(3-4). 430–430. 8 indexed citations
18.
Zilliken, F. & M. W. Whitehouse. (1958). The Nonulosaminic Acids. PubMed. 13. 237–263. 30 indexed citations
19.
Kent, P. W. & M. W. Whitehouse. (1955). Biochemistry of aminosugars. 50 indexed citations
20.
Whitehouse, M. W., P. W. Kent, Rudolph Peters, & E. C. Foulkes. (1954). Further observations on factors influencing the utilization of citrate by yeast. Biochemical Journal. 58(3). 437–440. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026